Natus Medical announces $50M revolving credit facility with Wells Fargo Bank

Natus Medical Incorporated (Nasdaq:BABY) today announced that it has entered into a $50 million revolving credit facility with Wells Fargo Bank, National Association. The credit facility, which matures on April 30, 2012, amends and restates the Company's existing $25 million credit facility that was scheduled to mature on April 30, 2010.

“As we currently have sufficient working capital and believe we will generate positive operating cash flows during the term of the facility, we expect that any borrowings under the credit facility will be used for strategic acquisitions”

Jim Hawkins, President and Chief Executive officer of the Company said, "Given that credit markets are still restrictive, we view the increase in our borrowing capacity to $50 million as evidence of the strength of our business. We are pleased to have such a good relationship with Wells Fargo Bank."

"As we currently have sufficient working capital and believe we will generate positive operating cash flows during the term of the facility, we expect that any borrowings under the credit facility will be used for strategic acquisitions," added Hawkins.

SOURCE Natus Medical Incorporated

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study aims to reduce C-section rates in pregnant women with obesity